OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
29
Results
Show all
Save search
Copy query
Show results for
Unknown
(29)
Publication Date
Release Date
2022
(5)
2025
(3)
2024
(3)
2021
(3)
2014
(3)
2013
(3)
2023
(2)
2016
(2)
2015
(2)
2020
(1)
2012
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
Not available
S-EPMC7346765
|
biostudies-literature
Cite
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Not available
S-EPMC8220972
|
biostudies-literature
Cite
Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
Not available
S-EPMC11075869
|
biostudies-literature
Cite
Characterizing Long COVID in Children and Adolescents.
Not available
S-EPMC11339705
|
biostudies-literature
Cite
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.
Not available
S-EPMC7936352
|
biostudies-literature
Cite
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age.
Not available
S-EPMC3725578
|
biostudies-literature
Cite
Aerosol precautions and airway complications: a national prospective multicentre cohort study.
Not available
S-EPMC10087829
|
biostudies-literature
Cite
Factors associated with D-dimer levels in HIV-infected individuals.
Not available
S-EPMC3953205
|
biostudies-literature
Cite
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets